Anas Younes

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Anas Younes

Jul 19, 2024, 14:44 | Blog

"What’s Next for Immunotherapies?" by Anas Younes

Anas Younes shared a post on LinkedIn: Immunotherapies Immunotherapies "My interview with Mark Cobbold, Senior…

Feb 19, 2024, 18:18 | Blog

Anas Younes: We are developing more than one drug for the same disease indication, so we can build future combination regimens

Anas Younes posted on LinkedIn: ''Our hematology team spent the last 3 days reviewing our…

Dec 27, 2023, 13:52 | Blog

Anas Younes: It is time to take a rest to recharge

Anas Younes posted on X/Twitter: "As we get closer to the end of the year,…

Sep 26, 2023, 17:34 | Opinion

Anas Younes: I think there is a need to reset expectations of what a physician scientist (PS) means.

Anas Younes, Senior VP, Global Head of Hematology (Early and Late Stage), Oncology R&D at…

Sep 16, 2023, 17:33 | Blog

Anas Younes: This Blood Cancer Awareness Month, it’s important to highlight the critical need for innovative treatment options for people living with hematological malignancies.

Aug 16, 2023, 18:22 | Opinion

Anas Younes: Interesting report, although I disagree with some of the comments.

In a LinkedIn post, Anas Younes, Senior VP, Global Head of Hematology (Early and Late…

Jun 22, 2023, 19:15 | Positive

We are at a pivotal time for treatment innovations in hematological malignancies - Anas Younes

We are at a pivotal time for treatment innovations in hematological malignancies, and our data…

All: 7 Posts: 1 - 100